Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase NA 3Phase 4 2Phase 1 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1CNS 1

Conditions

Vomiting 3Lymphoma, Mantle-Cell 2Nausea 1Lymphoma 1Leukemia, Mast-Cell 1Glioma 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Granisetron × Clear all
NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Stanford University

Phase 2 Completed
36 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell

NCT00450801 2015-11-10

R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma

University of Miami

Phase 2 Completed
22 enrolled 9 charts
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT00003817 2015-10-15

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

University of Rochester

Phase 2 Completed
700 enrolled

Nausea, Vomiting

NCT00450853 2015-01-27

Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients

Clinica Universidad de Navarra, Universidad de Navarra

Phase 2 Completed
31 enrolled

Vomiting

NCT01952886 2014-09-22

Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients

Duke University

Phase 2 Withdrawn
CNS

Glioma

NCT00666783 2008-04-25

An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients

Xijing Hospital

Phase 2 Completed
208 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡